Antiretroviral Agents in HIV-1 (trial)

DHHS Adult HIV 2013

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/309990

Contents of this Issue

Navigation

Page 3 of 31

2 Assessment and Diagnosis Baseline Evaluation Î HIV antibody testing (AI) Î CD4 T-cell count (AI) Î Plasma HIV RNA (viral load) (AI) Î Complete blood count (AIII) Î Chemistry profile (AIII) Î Transaminase levels (AIII) Î BUN and creatinine (AIII) Î Urinalysis (AIII) Î Screening test for syphilis (eg, RPR, VDRL, or treponema EIA) (AIII) Î Tuberculin skin test (TST) or interferon-gamma release assay (IGRA) (unless there is a history of prior tuberculosis or positive TST or IGRA) (AIII) Î Anti-Toxoplasma gondii IgG (AIII) Î Hepatitis A, B, and C serologies (AIII) Î Pap smear in women (AIII) Î Fasting blood glucose and serum lipids (AIII) Î Resistance testing (see page 3) Î Testing for Chlamydia trachomatis and Neisseria gonorrhoeae (BII) Î Chest x-ray in the presence of pulmonary symptoms or with a positive TST or IGRA test (BIII)

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 (trial) - DHHS Adult HIV 2013